Aminoisobutyric Acid Application: Industrial

Dr. Habil Khorakiwala founded Wockhardt in 1967. Today, the Wockhardt Group is IndiaA AcA A A A s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients (APIs) and Super Speciality Hospitals. An alumnus of Purdue University and Harvard Business School, he was the A A A A first non-American to be conferred with an Honorary Doctorate in 125 years by Purdue University (Pharmacy School) in 2010. A member of the World Economic Forum, Dr. Khorakiwala has held many senior positions as an industry representative, and has been lauded and awarded by various institutions and organisations. As a former president of FICCI (Federation of Indian Chambers of Commerce & Industry), he has met and shared IndiaA AcA A A A s business and economic dynamics with many Presidents, Prime Ministers and Heads-of-State. He has also served as the president of IPA (Indian Pharmaceutical Alliance); as the Chairman of the Board of Governors at the Centre for Organisation Development in Hyderabad, a non-profit, scientific and industrial research organisation and a recognised doctoral research centre; and as the Chancellor of Jamia Hamdard University, New Delhi, which has emerged as an outstanding institution of higher learning with distinct and focused academic programmes. In 2017, Dr. Khorakiwala authored A AcA A A A Odyssey of CourageA AcA A A A , a book chronicling his entrepreneurial journey, and in 2018, he established the Wockhardt School of Courage, a unique mentorship programme for young and budding entrepreneurs, which is based on tenets, principles and insights drawn from the book.